Boehringer Ingelheim Investigational Site
Houston, Texas 77004
0 studies enrolling now · 10 studies all time
What they study most
Diabetes Mellitus, Type 2, HIV Infections, Hypertension, Pulmonary Disease, Chronic Obstructive
Studies at this site
- A Multiple Dose Comparison of Tiotropium Inhalation Capsules and Salmeterol Inhalation Aerosol. — Completed
- Dual Boosted - Protease Inhibitor (PI) Pharmacokinetics (PK) Trial (Tipranavir / Ritonavir) in Highly Treatment-experienced HIV-1 Infected Patients — Completed
- 3 TPV/RTV Doses in Multiple ARV Experienced Patients - Tipranavir Dose Defining Study — Completed
- MARLINA - T2D : Efficacy, Safety & Modification of Albuminuria in Type 2 Diabetes Subjects With Renal Disease With LINAgliptin — Completed
- Tiotropium / Respimat One-Year Study — Completed
- Tiotropium / Respimat One-Year Study — Completed
- Utilization of HIV Drug Resistance Testing in Treatment Experienced Patients (UTILIZE Study) — Completed
- A Randomized, Double-blind, Placebo Controlled Comparison of Telmisartan Hydrochlorothiazide (HCT) and Valsartan HCT in Hypertension (HTN) Stage I/II Patients — Completed
- Efficacy and Safety (Including 24-hour Holter Monitoring) of Tiotropium Inhalation Capsules in Patients With COPD — Completed
- High Dose Trial in COPD — Completed